Introduction
============

Periodontal diseases are one of the most common diseases worldwide and include the inflammatory disorders gingivitis and periodontitis ([@b1-mmr-19-05-3649]). Besides conventional treatment that controls inflammation, stem cell-based regeneration of periodontal ligaments and other periodontal tissues brings new hope for patients suffering from severe periodontal diseases ([@b2-mmr-19-05-3649],[@b3-mmr-19-05-3649]). Among the various types of adult multipotent cells, periodontal ligament stem cells (PDLSCs) are multipotent stem cells that are capable of differentiating into alveolar bone, cementum, peripheral nerves and even blood vessels ([@b4-mmr-19-05-3649]--[@b8-mmr-19-05-3649]). However, the amounts of residual PDLSCs are limited and *in vitro* expanded PDLSCs may serve as an alternative source of stem cells for applications in the regeneration of periodontal tissues. External stimuli and genetic backgrounds, including hypoxia, hormones, histone modification and non-coding RNAs, affect the quality and function of PDLSCs ([@b9-mmr-19-05-3649]--[@b15-mmr-19-05-3649]). Oxidative stress is characterized by misregulated reactive oxygen species (ROS) which are primarily generated from mitochondrial complexes I and III. A basal level of ROS is required for normal cell activities. However, if free radicals are abnormally accumulated, important biomolecules including DNA and proteins are negatively affected and the survival of stem cells is compromised ([@b16-mmr-19-05-3649],[@b17-mmr-19-05-3649]). Although oxidative stress is critical for stem cell aging and survival ([@b18-mmr-19-05-3649]--[@b20-mmr-19-05-3649]), it is not clear whether oxidative stress impacts the molecular regulation of PDLSCs *in vitro*.

cAMP responsive element binding protein (Creb) was initially identified within the rat brain as a transcription factor, and the phosphorylation of Creb at serine 133 is required for its transcriptional activity ([@b21-mmr-19-05-3649]--[@b24-mmr-19-05-3649]). Since this discovery, various functions of Creb have been described and \>4,000 genes contain the cAMP responsive element in their promoter regions ([@b25-mmr-19-05-3649]). Creb regulates cell proliferation, differentiation and survival, in addition to inflammation, in various type of cells ([@b26-mmr-19-05-3649]). Since Creb is stimulated by various extracellular signals, such as hypoxia and hormones, it is of interest to examine the role of Creb in PDLSCs ([@b25-mmr-19-05-3649]).

Mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) phosphorylates Creb at SER 133 via ribosomal S6 kinase ([@b27-mmr-19-05-3649],[@b28-mmr-19-05-3649]). Previous reports suggest that the ERK1/2 pathway is required for PDLSC differentiation ([@b29-mmr-19-05-3649],[@b30-mmr-19-05-3649]) suggesting that ERK-mediated phosphorylation of Creb may regulate PDLSCs. Of note, administration of H~2~O~2~ increases the phosphorylation level of ERK1/2, but reduces the phosphorylation level of Creb at SER 133, suggesting that ERK-Creb signaling is modulated by oxidative stress in PC12 cells ([@b31-mmr-19-05-3649]). A recent report demonstrated that Creb/ERK signaling inhibits oxidative stress in osteoblast cells ([@b32-mmr-19-05-3649]). Evidence also suggests that ERK-dependent Creb activation reduces apoptosis in human neuroblastoma cells ([@b33-mmr-19-05-3649]). Thus, it is possible that the ERK/Creb pathway regulates PDLSCs in an oxidative stress-dependent manner and controls the apoptosis of PDLSCs.

Phosphorylated Creb is able to bind directly to the apoptosis regulator Bcl-2 (Bcl-2) promoter and induce the transcription of Bcl-2, which in turn rescues B cells from apoptosis ([@b34-mmr-19-05-3649]). In addition, Creb-mediated Bcl-2 expression also protects Hela cells from apoptosis ([@b35-mmr-19-05-3649]). Bcl-2 is an anti-apoptotic regulator which negatively controls the apoptosis process by inhibiting cytochrome *c* release, while apoptosis regulator BAX is a pro-apoptotic regulator which facilitates the release of cytochrome *c* ([@b36-mmr-19-05-3649]). Selenite inhibits the phosphorylation of Creb and reduces the level of Bcl-2, resulting in apoptosis, whereas apricot increases the expression of Bcl-2 and Creb and attenuates oxidative stress ([@b37-mmr-19-05-3649],[@b38-mmr-19-05-3649]). U0126 is a specific inhibitor of dual specificity mitogen-activated protein kinase kinase 1, an upstream kinase of ERK1/2 ([@b39-mmr-19-05-3649],[@b40-mmr-19-05-3649]). By using U0126, it may be possible to validate the association between ERK and Creb. These previous results indicated that Creb-mediated Bcl-2 expression is critical for oxidative stress and apoptosis, suggesting that the Creb/Bcl-2 pathway may be involved in regulating PDLSCs.

The present study aimed to reveal the role of Creb in H~2~O~2~-induced oxidative stress in PDLSCs. The expression alteration of Creb upon administration of H~2~O~2~ was assessed. Creb was overexpressed in PDLSCs to study its function. The ROS level in wild-type PDLSCs and PDLSCs overexpressing Creb was also monitored under treatment with H~2~O~2~. To reveal the mechanism of Creb-mediated PDLSC protection, ERK/Creb/Bcl-2 signaling was examined. The results revealed a protective role of Creb against H~2~O~2~-induced oxidative stress, and provided evidences for the further application of PDLSCs in regenerative medicine.

Materials and methods
=====================

### Periodontal ligament stem cell isolation and culture

The rat PDLSCs were isolated by modifying a method described previously ([@b41-mmr-19-05-3649]). Five female Wistar rats (age, 8 weeks; weight, 250±50 g; Zhejiang Center of Laboratory Animals, Hangzhou, China) were housed under standardized conditions: Room temperature, 20--24°C; relative air humidity, 35--70%; 12-h light/dark cycle. The animals had free access to standard laboratory food (Zhejiang Center of Laboratory Animals) and sterile water. The rat periodontal ligaments were cut into small pieces and digested in 0.3% collagenase (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) at 37°C for 4 h. The cells obtained were pooled, seeded and cultured in Dulbecco\'s modified Eagle\'s medium (HyClone; GE Healthcare Life Sciences, Logan, UT, USA) containing 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) in a humidified atmosphere (95% air, 5% CO~2~) at 37°C. STRO-1^+^ PDLSCs were purified using immunomagnetic beads (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer\'s protocol. Attracted cells were segregated using a magnetic particle separator following three washes with isolation buffer (PBS with 0.1% bovine serum albumin (Sigma-Aldrich; Merck KGaA) and 2 mM EDTA). Subsequently cells were seeded and cultured in growth medium in a humidified atmosphere (95% air, 5% CO~2~) at 37°C.

The animal care and protocols were approved by the Institutional Review Boards of Zhejiang University (Hangzhou, China; approval no. ZJUAC160809012).

### H~2~O~2~ treatment

The cells were treated with 62.5, 125, 250, 500 and 1,000 µM H~2~O~2~ for 24 h to detect the influence of oxidative stress on Creb expression. Cells treated with an equivalent volume of PBS were used as a control. In subsequent experiments, the cells were treated with 125 µM H~2~O~2~ to induce oxidative stress.

For the ERK inhibition assay, 10 µM ERK-specific inhibitor U0126 (Promega Corporation, Madison, WI, USA) dissolved in dimethyl sulfoxide (DMSO) was added into the culture medium for 1 h prior to treatment with H~2~O~2~. An equal volume of DMSO was used as the vehicle control.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Total RNA was extracted from PDLSCs using TRIzol^®^ reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer\'s protocol. For each sample, 500 ng total RNA was reverse-transcribed using GoScript™ RT system (Promega Corporation) according to the manufacturer\'s protocol. The resulting cDNA was diluted 40 times and RT-qPCR was performed with the Ace Q qPCR SYBR Green Master Mix kit (Vazyme, Piscataway, NJ, USA). PCR amplification was conducted as follows: Preheating at 95°C for 5 min, followed by 40 cycles of denaturation at 95°C for 10 sec and annealing/extension at 60°C for 30 sec. Data were quantified using the 2^−ΔΔCq^ method as previously described ([@b42-mmr-19-05-3649]). The following primers were used in the tests: Rat GAPDH forward, 5′-AACGACCCCTTCATTGACC-3′ and reverse, 5′-TCCACGACATACTCAGCACC-3′; rat Creb forward, 5′-CACATAGCCCAGGTATCC-3′ and reverse, 5′-TGAACTGTTTGGACTTGTGG-3′.

### Western blotting

Total proteins were extracted from PDLSCs using radioimmunoprecipitation assay lysis buffer (Thermo Fisher Scientific, Inc.) and were quantified using the Pierce Bicinchoninic Acid Protein Assay kit (Thermo Fisher Scientific, Inc.) according to the manufacturers\' protocols. Extracted proteins from each sample (25 µg) were separated with 10% SDS-PAGE and transferred onto a nitrocellulose membrane (Thermo Fisher Scientific, Inc.). The membrane was blocked with 5% milk in TBS with Tween-20 (TBST; Bio-Rad Laboratories, Inc., Hercules, CA, USA) for at least 1 h at room temperature and subsequently incubated with each primary antibody overnight at 4°C. Membranes were washed with TBST buffer at least five times for 5 min and incubated with the secondary antibodies for 1 h at room temperature. The protein bands were visualized using an enhanced chemiluminescence system (Amersham; GE Healthcare, Chicago, IL, USA). Equal loading of samples was verified by immunoblotting for GAPDH (1:10,000, cat. no. ab181602; Abcam, Cambridge, UK). The primary antibodies used in the present study were anti-Creb antibody (1:500, cat. no. ab32515), anti-phospho-Creb antibody (1:5,000, cat. no. ab32096), anti-Bcl-2 antibody (1:500, cat. no. ab59348), anti-caspase-9 (1:500, cat. no. ab25758), anti-ERK (1:1,000, cat. no. ab17942) and anti-phospho-ERK (1:1,000, cat. no. ab201015) (all from Abcam). All primary antibodies were further labeled with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:5,000, cat. no. ab6721; Abcam). Densitometric quantification was performed using ImageJ software (version 1.46; National Institutes of Health, Bethesda, MD, USA).

### MTT assays

PDLSCs treated with various concentrations of H~2~O~2~ for 24 h were plated at a density of 1×10^4^ cells/well in a 96-well plate. Viable cells were stained with 0.25 mg/ml MTT for 1 h at 37°C. The media were then removed, and formazan crystals produced were dissolved by the addition of DMSO (absorbance, 540 nm).

### Creb overexpression

A plasmid based on the pcDNA3.1 backbone (Addgene, Inc., Cambridge, MA, USA) overexpressing Creb was obtained by cloning full-length human Creb cDNA by PCR with the following primers: Forward, 5′-GGGAATTCCCGGTAACTAAATG-3′ and reverse, 5′-GGGCGGCCGCTTGTCTTTCAGGTTGTGG-3′. The primers were designed according to the Creb sequence provided by the National Center for Biotechnology Information database (GeneBank ID: AY347527.1; [www.ncbi.nlm.nih.gov/genbank](www.ncbi.nlm.nih.gov/genbank)). The resultant cDNA was verified by sequencing (Beijing Genomics Institute, Beijing, China) and inserted into the backbone plasmid between the *Not*I and *Eco*RI cloning site. Plasmid pcDNA3.1 was used as a vector control. PDLSCs were seeded in 60-mm dishes at 5×10^5^ cells/dish and incubated overnight prior to transfection with 1 µg plasmid DNA using jetPRIME™ DNA and transfection reagent (VWR International, Ltd., Lutterworth, UK), according to the manufacturer\'s protocol. After 24 h, the cell lysates were collected for western blotting or RT-qPCR.

### Measurement of ROS

The intracellular ROS level was measured via the oxidation of the ROS-sensitive fluorophore 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA; Thermo Fisher Scientific, Inc.), according to the manufacturer\'s protocol. PDLSCs were loaded with 5 µM probe in buffers supplied by the manufacturer, and incubated in a humidified atmosphere (95% air, 5% CO~2~) at 37°C for 30 min. The cells were washed and measured using a luminescence spectrometer (PerkinElmer, Inc., Waltham, MA, USA) with an excitation source at 488 nm and an emission at 530 nm.

### Estimation of lipid peroxidation

Malondialdehyde (MDA) reacts with thiobarbituric acid to produce a fluorescent product. The level of MDA was measured in PDLSC lysates with a microplate reader at a wavelength of 535 nm. PDLSCs at an estimated density of 2.5×10^5^ were harvested and washed with PBS after 24 h. The MDA was measured according to the manufacturer\'s protocol of the MDA detection kit (Beyotime Institute of Biotechnology, Haimen, China).

### DCFDA staining

Cellular ROS production was measured using a DCFDA assay kit, as previously reported ([@b43-mmr-19-05-3649]). Briefly, PDLSCs were incubated with 25 µM DCFDA at 37°C for 45 min, and then exposed to hyperosmotic medium (450 mOsM). Fluorescent images were captured using a Nikon Eclipse Ti microscope (Nikon Corporation, Tokyo, Japan). Images were captured at ×400 magnification.

### Flow cytometry

PDLSCs were stained with DCFDA as described above and resuspended in PBS. Fluorescence was measured by FACSCalibur flow cytometry (BD Biosciences). Data were analyzed and graphed using Beckman Coulter Epics XL-MCL running System II software (version 3.0; Beckman Coulter, Inc., Brea, CA, USA).

### Statistical analysis

Data are presented as the mean ± standard deviation and at least three separate experiments were performed. Student\'s t-tests were performed to assess significant differences between two groups, and comparisons among multiple groups were conducted using single-factor analysis of variance with Tukey\'s post hoc test. Statistical calculations were performed using SPSS 20.0 (IBM Corp., Armonk, NY, USA). P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Hydrogen peroxide impairs the expression of Creb

Rat PDLSCs were isolated and characterized ([Fig. S1](#SD1-mmr-19-05-3649){ref-type="supplementary-material"}), and were then used to examine the expression levels of Creb under oxidative stress. After treating the primary PDLSCs with H~2~O~2~ at concentrations of 0, 62.5, 125, 250, 500 and 1,000 µM for 24 h, the results demonstrated that the mRNA and protein expression levels of Creb were significantly reduced upon treatment with H~2~O~2~ treatment in a dose-dependent manner ([Fig. 1A and B](#f1-mmr-19-05-3649){ref-type="fig"}), suggesting that the expression of Creb is negatively controlled by H~2~O~2~. Since H~2~O~2~ concentrations of 125 µM or higher reduced Creb expression by \>50%, 125 µM was selected as the half-maximal effective dose of H~2~O~2~, and this concentration was used for the following studies.

### Overexpression of Creb protects PDLSCs from H~2~O~2~-induced cytotoxicity

To further explore the role Creb of PDLSCs, a Creb-overexpressing plasmid was constructed and transfected into isolated PDLSCs. RT-qPCR and western blotting demonstrated significant overexpression of Creb at the mRNA and protein levels ([Fig. 2A and B](#f2-mmr-19-05-3649){ref-type="fig"}). In the presence of H~2~O~2~, cell viability assessed by MTT assay in PDLSCs decreased significantly ([Fig. 2C](#f2-mmr-19-05-3649){ref-type="fig"}). However, PDLSCs with overexpressed Creb displayed a higher survival rate compared with wild-type PDLSCs ([Fig. 2C](#f2-mmr-19-05-3649){ref-type="fig"}). Meanwhile, we did not observe a significant difference in cell viability between wild-type PDLSCs and Creb over-expressing PDLSCs under normal culture conditions ([Fig. 2C](#f2-mmr-19-05-3649){ref-type="fig"}).

### Creb overexpression attenuates H~2~O~2~-induced ROS damage

To understand how Creb rescues PDLSCs from H~2~O~2~-induced cytotoxicity, the ROS resulting from H~2~O~2~ treatment were first analyzed. Treatment with H~2~O~2~ caused a significant induction of ROS in PDLSCs, and overexpression of Creb significantly attenuated the ROS to approximately basal levels ([Fig. 3A](#f3-mmr-19-05-3649){ref-type="fig"}). Additionally, the MDA level induced by treatment with H~2~O~2~ was also recovered by the overexpression of Creb ([Fig. 3B](#f3-mmr-19-05-3649){ref-type="fig"}), suggesting that Creb protected PDLSCs from H~2~O~2~-induced ROS damage. Upon oxidation, H~2~DCFDA becomes the highly green fluorescent DCFDA, providing an excellent tool for ROS detection. H~2~DCFDA was applied to the culture media and the fluorescent signals were examined. The results demonstrated that H~2~O~2~ administration induced strong fluorescent signals, while Creb overexpression effectively attenuated the signals ([Fig. 3C](#f3-mmr-19-05-3649){ref-type="fig"}). The DCFDA fluorescence intensity was also measured by flow cytometry, and the results indicated that the cells treated with H~2~O~2~ exhibited high DCFDA fluorescence intensity, while the fluorescence intensity was significantly reduced in Creb-overexpressing PDLSCs ([Fig. 3D](#f3-mmr-19-05-3649){ref-type="fig"}).

### Creb overexpression leads to activation of Creb/Bcl-2/Caspase signal

Creb is a critical regulator of the anti-apoptotic protein Bcl-2 and phosphorylated Creb protein directly induces the expression of Bcl-2. The present results demonstrated that in Creb-overexpressing PDLSCs, Bcl-2 expression was induced ([Fig. 4](#f4-mmr-19-05-3649){ref-type="fig"}). When the PDLSCs were treated with H~2~O~2~, the protein expression of Creb, phosphorylated Creb and Bcl-2 were all impaired while cleaved caspase-9, an initiator of apoptosis, was significantly increased ([Fig. 4](#f4-mmr-19-05-3649){ref-type="fig"}). In Creb-overexpressing PDLSCs, the activation of caspase-9 was efficiently attenuated due to the induction of Bcl-2 ([Fig. 4](#f4-mmr-19-05-3649){ref-type="fig"}), suggesting that Creb/Bcl-2/caspase signaling is a critical pathway that regulates apoptosis in PDLSCs.

### Inhibition of ERK pathway abrogates Creb-induced ROS resistance

ERK signaling regulates Creb activity and oxidative stress modulates the phosphorylation of ERK. The results in PDLSCs demonstrated that treatment with H~2~O~2~ induces the expression of phosphorylated ERK, and administration of U0126, a highly selective inhibitor of ERK, resulted in the near-total ablation of phosphorylated ERK and phosphorylated Creb ([Fig. 5A](#f5-mmr-19-05-3649){ref-type="fig"}). In addition, Creb overexpression significantly increased the expression level of phosphorylated Creb, even under treatment with H~2~O~2~, while inhibition of the ERK pathway by U0126 abrogated the induced expression of phosphorylated Creb ([Fig. 5B](#f5-mmr-19-05-3649){ref-type="fig"}). As a result, the abrogation of phosphorylated Creb resulted in a marked decrease in the cell viability of Creb-overexpressing PDLSCs ([Fig. 5C](#f5-mmr-19-05-3649){ref-type="fig"}), suggesting that Creb-induced ROS resistance in PDLSCs depends on ERK activity.

Discussion
==========

Oxidative stress is accompanied by inflammation, and increasing evidence suggests that inflammation weakens the regenerative capacity of PDLSCs, although the proliferation and migration of PDLSCs may be strengthened ([@b44-mmr-19-05-3649],[@b45-mmr-19-05-3649]). However, little is known about how PDLSCs respond to oxidative stress. As a promising cell source for regenerative medicine, it is of great importance to understand how PDLSCs are regulated under various external stimuli. In the present study, the results revealed that under treatment with H~2~O~2~, mRNA and protein expression of Creb were significantly reduced in a dose-dependent manner, suggesting a regulatory role of Creb in PDLSCs. More importantly, enhanced Creb expression protected PDLSCs from H~2~O~2~-induced cytotoxicity. The present findings suggested that Creb expression is closely associated with the survival of PDLSCs. Modulating Creb expression may be a way of improving the *in vitro* culture efficiency of PDLSCs in the repair of periodontal ligaments.

A significant increase in ROS levels was observed by monitoring ROS, MDA and DCFDA intensities, suggesting that PDLSCs are sensitive to environmental stimuli. PDLSCs are very sensitive to ROS stimulation. It has been reported that the phosphatidylinositol 3-kinase/RAC-α serine/threonine protein kinase and β-catenin pathways are affected when PDLSCs are subjected to ROS stimulation. The present data revealed a *de novo* pathway that involves Creb protein, which shares a crosstalk with the β-catenin pathways ([@b42-mmr-19-05-3649],[@b46-mmr-19-05-3649]). Elevated ROS levels are associated with apoptosis and Bcl-2 is a critical regulator in ROS-associated apoptosis ([@b47-mmr-19-05-3649]--[@b49-mmr-19-05-3649]), suggesting that apoptotic cell death caused at least a portion of the PDLSCs cell death under the treatment with H~2~O~2~. Multiple results have demonstrated the role of Bcl-2 in apoptosis and there is a need to identify the upstream regulators of Bcl-2 ([@b50-mmr-19-05-3649]--[@b52-mmr-19-05-3649]). The present results demonstrated that the induction of Creb expression attenuated the H~2~O~2~-induced ROS elevation, suggesting that Creb protects PDLSCs from apoptosis by activating Bcl-2. As an upstream regulator of Bcl-2, activation of Creb increases the expression of Bcl-2 resulting in reduced apoptosis ([@b34-mmr-19-05-3649],[@b35-mmr-19-05-3649]). The present results demonstrated that Creb-mediated Bcl-2 induction was impaired by the administration of hydrogen peroxide, while apoptosis-specific c-caspase-9 was significantly increased. Upregulation of c-caspase-9 indicates an increased level of apoptosis ([@b53-mmr-19-05-3649]). Besides, the Creb-caspase-9 axis is a critical apoptosis regulator during cancer development ([@b54-mmr-19-05-3649]). Overexpression of Creb successfully restored the level of phosphorylated Creb, which attenuated the expression of Bcl-2. In the presence of Bcl-2, the expression of the apoptotic protein caspase-9 was inhibited and the cell viability was restored. The present results suggested that inhibition of the apoptotic cascade is at least one way in which Creb is able to protect PDLSCs from oxidative stress-induced cytotoxicity.

Creb is involved in multiple signaling pathways that regulate various cellular processes ([@b55-mmr-19-05-3649]--[@b57-mmr-19-05-3649]). In the nervous system, Creb is a critical regulator that modulates cell death and synaptic activity through ERK phosphorylation ([@b58-mmr-19-05-3649],[@b59-mmr-19-05-3649]). The phosphorylation of ERK and Creb is regulated distinctly in the presence of H~2~O~2~ ([@b31-mmr-19-05-3649]). Administration of H~2~O~2~ increases phosphorylated ERK, but decreases phosphorylated Creb ([@b31-mmr-19-05-3649]). The present results in PDLSCs agreed with these previous findings in PC12 cells. However, phosphorylated ERK generally increases the level of phosphorylated Creb and protects neuronal cells from apoptosis ([@b32-mmr-19-05-3649],[@b33-mmr-19-05-3649]). According to the present results, the H~2~O~2~-mediated decreased in Creb and ERK-mediated Creb phosphorylation are likely to be independent from one another. However, when the ERK-specific inhibitor U0126 was applied, the expression level of phosphorylated Creb was significantly decreased, suggesting that the activation of Creb largely depends on the activation of ERK signaling and the protective role Creb in PDLSC viability is MAPK/ERK-dependent. Thus, the results of the present study revealed signaling from the upstream MAPK/ERK signals to the downstream apoptotic inhibitor Bcl-2, and that Creb serves a critical role in this signaling in PDLSCs.

In conclusion, the present results demonstrated that the transcription factor Creb is tightly regulated in PDLSCs by environmental stimuli. Meanwhile, in PDLSCs, Creb is required for the expression of the anti-apoptotic protein Bcl-2. An appropriate level of phosphorylated Creb activated by MAPK/ERK signaling protects PDLSCs from apoptotic cell death. Mechanistically, these data suggested that treatment with H~2~O~2~ resulted in a significant upregulation of phosphorylated ERK, which in turn caused decreases in Creb and phosphorylated Creb. Therefore, the downstream apoptotic inhibitor Bcl-2 was downregulated, resulting in PDLSC apoptosis. The present results provide insights into PDLSC maintenance and, more importantly, further illustrate that the *in vitro* culture of PDLSCs designed for clinical applications may be improved by modulating the expression of Creb.

Supplementary Material
======================

###### Supporting Data

Not applicable.

Funding
=======

This study was supported by the Administration of Traditional Chinese Medicine of Zhejiang Province (grant no. 2014ZA069) and the Department of Education of Zhejiang Province (grant no. Y201534720).

Availability of data and materials
==================================

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors\' contributions
=======================

XF, BS, and YZ conceived and designed the experiments. XF performed the experiments. XF and YF analyzed the data and drafted the manuscript. BS and YZ revised the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate
==========================================

The animal care and protocols were approved by the Institutional Review Boards of Zhejiang University (Hangzhou, China; approval no. ZJUAC160809012).

Patient consent for publication
===============================

Not applicable.

Competing interests
===================

The authors declare that they have no competing interests.

Creb

:   cAMP responsive element binding protein

PDLSCs

:   periodontal ligament stem cells

ROS

:   reactive oxygen species

ERK

:   extracellular signal regulated kinase

DCFDA

:   2′,7′-dichlorodihydrofluorescein diacetate

![H~2~O~2~ treatment downregulates Creb expression in PDLSCs. (A) Reverse transcription-quantitative polymerase chain reaction and (B) western blot analysis of Creb expression after 24 h of treatment with H~2~O~2~ at the indicated concentrations. PDLSCs treated with an equivalent volume of PBS were used as the control. \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001 vs. respective control. PDLSCs, periodontal ligament stem cells; Creb, cAMP responsive element binding protein.](MMR-19-05-3649-g00){#f1-mmr-19-05-3649}

![Overexpression of Creb protects PDLSCs from H~2~O~2~-induced cytotoxicity. (A) Reverse transcription-quantitative polymerase chain reaction and (B) western blot analysis illustrating Creb expression in PDLSCs transfected with pcDNA3.1 or pcDNA3.1-Creb for 48 h. (C) A total of 48 h post-transfection, PDLSCs were treated with 125 µM H~2~O~2~ for 24 h, and cell viability was detected by MTT assay. \*P\<0.05 vs. respective control. PDLSCs, periodontal ligament stem cells; Creb, cAMP responsive element binding protein.](MMR-19-05-3649-g01){#f2-mmr-19-05-3649}

![Creb overexpression attenuates H~2~O~2~-induced ROS damage. PDLSCs with/without overexpression of Creb were exposed to H~2~O~2~ (125 µM) for 24 h, and the production of (A) ROS and (B) MDA was determined. (C) DCFDA staining illustrating the production of intracellular ROS. Scale bars, 50 µm. (D) The fluorescence intensity of DCFDA was measured by flow cytometry. Values are presented as the mean arbitrary unit ± standard deviation of three independent repeats. \*P\<0.05. PDLSCs, periodontal ligament stem cells; Creb, cAMP responsive element binding protein; ROS, reactive oxygen species; MDA, malondialdehyde; DCFDA, 2′,7′-dichlorodihydrofluorescein diacetate.](MMR-19-05-3649-g02){#f3-mmr-19-05-3649}

![Overexpression of Creb leads to activation of Creb/Bcl-2/Caspase signaling. Periodontal ligament stem cells with/without overexpression of Creb were exposed to H~2~O~2~ (125 µM) for 24 h. Creb, p-Creb, Bcl-2 and c-caspase-9 were detected by western blotting. Intracellular GAPDH was used as loading control. \*P\<0.05 vs. respective control. Creb, cAMP responsive element binding protein; p, phosphorylated; c, cleaved; Bcl-2, apoptosis regulator Bcl-2.](MMR-19-05-3649-g03){#f4-mmr-19-05-3649}

![Inhibition of the ERK pathway abrogates Creb-induced ROS resistance. (A) Treatment with the ERK inhibitor U0126 inhibits the activation of Creb. PDLSCs with/without overexpression of Creb were exposed to H~2~O~2~ (125 µM) for 24 h. ERK, p-ERK, Creb and p-Creb were detected by western blotting. (B) Inhibition of the ERK pathway attenuates Creb phosphorylation. PDLSCs with/without overexpression of Creb were treated with H~2~O~2~ (125 µM) for 24 h, 10 µM U0126 was used as an ERK specific inhibitor. Creb and p-Creb were detected by western blotting. Intracellular GAPDH was used as a loading control. (C) The viability of PDLSCs was detected by MTT assay. \*P\<0.05. ERK, extracellular signal-regulated kinase; p, phosphorylated; Creb, cAMP responsive element binding protein.](MMR-19-05-3649-g04){#f5-mmr-19-05-3649}
